We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Core Vct I | LSE:CR. | London | Ordinary Share | GB00B03FH337 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 72.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
14/11/2016 12:11 | ZBO - quite some nice steady call for them today. Not all that many peeps bought in during the extended Jan 2016 - Sept low, although a few stale bulls after the recent spike. But ZBO should show a sustained rise - particularly on the first solid good news.....by which time it'll likely be too late to catch the present cheapness, is what I reckon. f | fillipe | |
14/11/2016 12:02 | ODX showing interest there today + 6.9%. f | fillipe | |
14/11/2016 12:02 | don't be late for it FRR | crackdown2020 | |
14/11/2016 11:59 | VLG - a good strong update.... I'm surprised at not seeing some trades there - at one which has been steadily up-ticking since the low. I guess VLG will see some broker/tipster comment before long - they are in a popular and increasingly large area of the consumer market. f | fillipe | |
14/11/2016 11:33 | FRR is geating ready for a ride | crackdown2020 | |
14/11/2016 11:20 | BLUR is moving | crackdown2020 | |
14/11/2016 10:29 | Thanks for that cpap man. | noirua | |
14/11/2016 10:27 | LEG Brian Boru14 Nov '16 - 10:16 - 5605 of 5606 1 0 murmurings of VS float on LSE site........whilst I fully expect it to happen eventually I don't give too much credence to bb rumours, but nice to see a rise for whatever reason! Could in London but perhaps more likely on the NASDAQ | cpap man | |
14/11/2016 10:25 | Regent Pacific Group [HK:0575] the old PLE are absolutely flying at the moment! Well done to Noirua - great 0575 thread by the way! | cpap man | |
14/11/2016 10:23 | Added 888 Holdings - Taylor Wimpey TW. - Persimmon PSN - Bovis Homes BVN - Redrow RDW - Randgold RRS Reduced Univision UVEL to 4m shares - despite buyer in market at 0.85p. Probably company Chairman. Sold Arian AAU at 1.7p on Friday last. Sold half or RRR Red Rock - despite buyer sitting there around 0.388p. | noirua | |
14/11/2016 10:21 | MARL pr0t0n13 Nov '16 - 13:37 - 2109 of 2110 4 0 New MARL:TSX-V chart is in the header now. Results from the second batch are coming next week and then PEA as per latest interview with Glen. But, expect unexpected :-) POG ain`t helping, but I can`t see staying depressed for too long. | cpap man | |
14/11/2016 09:26 | DKL at resistance level of 11.75/12. decent news again today, surely won't be long before a break out here. | empirestate | |
14/11/2016 08:33 | ZBO - potential to go much higher, over time. Currently still close to its rock bottom price. Mkt Cap £2m....2016 sales £43m (!) Tightly held and only small showing on L2 at PEEL and WINS. f | fillipe | |
14/11/2016 08:32 | AFC Upon commerical deal this will be £1+. Considering todays news and the fact they are in talks with commerical partners its a HUGE buy from here | effiert | |
14/11/2016 08:14 | AFC Pretty amazing news here this morning i would say and a lot closer to commercial deals given that they are in talks already Suprised to see this open under 30p | effiert | |
14/11/2016 08:13 | YOLO will keep going till xmas. Robbie williams, sheryl crow, stephen fry, alicia dixon still yet to start their advertising campaigns on the product. Then watch it fly. QVC advertising starts soon also | effiert | |
14/11/2016 08:07 | YOLO Once again nice an' blue at YOLO | cpap man | |
14/11/2016 07:50 | ITM ITM Power plc ("ITM Power" or "the Company") Europcar UK Wins Funding for FCEVs, Signs Fuel Contract with ITM Power ITM Power (AIM: ITM), the energy storage and clean fuel company, is pleased to announce that it has signed a fuel contract, for the sale of hydrogen fuel at £10/kg, with Europcar UK. The fuel contract covers fuel dispensed across ITM Power's hydrogen refuelling network which has been financially supported by Innovate UK, OLEV and FCH JU. Europcar UK, subsidiary of Europcar Group, a European leader in vehicle rental services and a major player in mobility markets, announced today that it has been awarded a grant from OLEV enabling it to purchase "the largest privately owned fleet of hydrogen cars". ITM Power will be providing fuel for this new fleet of Toyota Mirai fuel cell electric vehicles. This is the sixth fuel supply contract ITM Power has signed and Europcar joins Hyundai, Toyota, Commercial Group, Arcola Energy and Arval as a fuel customer. -------------------- They've had a few Fuel contracts recently. | recordz | |
14/11/2016 07:43 | MWE MTI Wireless Edge Ltd ("MTI" or the "Company") Financial results for the nine months ended 30 September 2016 MTI Wireless Edge Ltd. (AIM: MWE), a market leader in the manufacture of flat panel antennas for fixed wireless broadband and a wireless irrigation solution provider, today announces its unaudited results for the nine months ended 30 September 2016 (the "Period"). Highlights: · Revenue increased by 31 per cent. year-on-year in the Period to US$17.6m (nine months to 30 September 2015: US$13.4m), primarily due to the acquisition of Mottech. · Gross profit increased by 22 per cent. year-on-year to US$6.5m (nine months to 30 September 2015: US$5.4m). · Operating profit of approximately US$1.0m in the Period, in line with nine months to 30 September 2015. · Cash flow generated from operations tripled to US$1.5m (nine months to 30 September 2015: US$0.5m). · Dividend of US 1.1 cent per share for the year ended 31 December 2015 paid on 1 April 2016. · Shareholders' equity of US$18.6m (at 30 September 2015: US$17.9m) after payment of dividend, equivalent to 28.9 pence per share. | recordz | |
14/11/2016 07:38 | AKR Akers Biosciences, Inc. Financial Results for the Third Quarter Ended September 30, 2016 Sales of Flagship Rapid HIT Test +341% over Q3 2015 - Total Revenue +262% Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers," "Akers Bio" or the "Company"), a developer of rapid health information technologies, reports its financial results for the third quarter ended September 30, 2016. The Form 10-Q containing the full financial statements for the third quarter - and nine months - ended September 30, 2016 will be available for viewing on the Company's website later today at www.akersbio.com or www.sec.gov. Q3 Financial Highlights: Total Revenue - all from product sales - up 262% to $613,198 (Q3 2015: $169,473) Sales of flagship PIFA Heparin/PF4 Rapid Assay products up 341% to $514,839 (Q3 2015: $116,783) - entirely from US-based customers Significant improvement in gross margin to 61% (Q3 2015: (5)%) as a result of higher selling prices, improved volumes and different component mix on core products Gross profit of $376,498 (Q3 2015: $(8,479)) Major reductions in costs in all key areas of the business: General and Administrative costs (27)%, Sales and Marketing costs (28)%, Research and Development costs (23)% Profit before tax in the quarter of $310,155 (Q3 2015: $(2,326,893)) following the reversal of an allowance for bad debts of $1,299,609 Loss before income tax (excluding the reversal of bad debt allowance) more than halved to $(989,454) (Q3 2015: $(2,326,893)) Cash and marketable securities at September 30, 2016 of $795,802 (December 31, 2015: $4,472,163) | recordz | |
12/11/2016 15:43 | Only one share Monday if you can get in and that's GCM, rose over 400p on speculation last time | letmepass | |
12/11/2016 12:11 | YOLO Very strong share price performance from YOLO closing at the highs for the day at YOLO of 1.50p on really decent volumes. Next week should be most interesting for YOLO!!!! | cpap man |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions